Menu

Filtros : "Drug Testing and Analysis" Removido: "2019" Limpar

Filtros

Refine with date range

  • 1

1 - 3 (3 records)

  • Artigo de periodico

    Pre‐workout supplements marketed in Brazil: caffeine quantification and caffeine daily intake assessment (2022)

    Costa, Bruno Ruiz Brandão da ; El Haddad, Lohanna Pereira; Freitas, Bruno Toledo; Marinho, Pablo Alves; De Martinis, Bruno Spinosa

    Source: Drug Testing and Analysis. Unidades: FFCLRP, FCFRP

    Subjects: CAFEÍNA, SUPLEMENTOS DIETÉTICOS, RÓTULOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      COSTA, Bruno Ruiz Brandão da et al. Pre‐workout supplements marketed in Brazil: caffeine quantification and caffeine daily intake assessment. Drug Testing and Analysis, v. 14, n. 3, p. 567-577, 2022Tradução . . Disponível em: https://doi.org/10.1002/dta.3043. Acesso em: 05 dez. 2025.

    • APA

      Costa, B. R. B. da, El Haddad, L. P., Freitas, B. T., Marinho, P. A., & De Martinis, B. S. (2022). Pre‐workout supplements marketed in Brazil: caffeine quantification and caffeine daily intake assessment. Drug Testing and Analysis, 14( 3), 567-577. doi:10.1002/dta.3043

    • NLM

      Costa BRB da, El Haddad LP, Freitas BT, Marinho PA, De Martinis BS. Pre‐workout supplements marketed in Brazil: caffeine quantification and caffeine daily intake assessment [Internet]. Drug Testing and Analysis. 2022 ; 14( 3): 567-577.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1002/dta.3043

    • Vancouver

      Costa BRB da, El Haddad LP, Freitas BT, Marinho PA, De Martinis BS. Pre‐workout supplements marketed in Brazil: caffeine quantification and caffeine daily intake assessment [Internet]. Drug Testing and Analysis. 2022 ; 14( 3): 567-577.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1002/dta.3043

  • Artigo de periodico

    Caffeine content of energy drinks marketed in Brazil (2022)

    Costa, Bruno Ruiz Brandão da ; Pereira El Haddad, Lohanna; Martinis, Bruno Spinosa de

    Source: Drug Testing and Analysis. Unidades: FFCLRP, FCFRP

    Subjects: CAFEÍNA, BEBIDAS ISOTÔNICAS, ADOLESCENTES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      COSTA, Bruno Ruiz Brandão da e PEREIRA EL HADDAD, Lohanna e MARTINIS, Bruno Spinosa de. Caffeine content of energy drinks marketed in Brazil. Drug Testing and Analysis, v. 14, n. 9, p. 1660-1664, 2022Tradução . . Disponível em: https://doi.org/10.1002/dta.3323. Acesso em: 05 dez. 2025.

    • APA

      Costa, B. R. B. da, Pereira El Haddad, L., & Martinis, B. S. de. (2022). Caffeine content of energy drinks marketed in Brazil. Drug Testing and Analysis, 14( 9), 1660-1664. doi:10.1002/dta.3323

    • NLM

      Costa BRB da, Pereira El Haddad L, Martinis BS de. Caffeine content of energy drinks marketed in Brazil [Internet]. Drug Testing and Analysis. 2022 ; 14( 9): 1660-1664.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1002/dta.3323

    • Vancouver

      Costa BRB da, Pereira El Haddad L, Martinis BS de. Caffeine content of energy drinks marketed in Brazil [Internet]. Drug Testing and Analysis. 2022 ; 14( 9): 1660-1664.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1002/dta.3323

  • Artigo de periodico

    In vitro metabolism of the lignan (-)-grandisin, an anticancer drug candidate, by human liver microsomes (2015)

    Barth, Thiago; Habenschus, Maísa Daniela; Moreira, Fernanda Lima; Ferreira, Leandro De Santis; Lopes, Norberto Peporine; Oliveira, Anderson Rodrigo Moraes de

    Source: Drug Testing and Analysis. Unidades: FCFRP, FFCLRP

    Subjects: BIOTRANSFORMAÇÃO, ANTINEOPLÁSICOS, TECNOLOGIA FARMACÊUTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BARTH, Thiago et al. In vitro metabolism of the lignan (-)-grandisin, an anticancer drug candidate, by human liver microsomes. Drug Testing and Analysis, v. 7, n. 9, p. 780-786, 2015Tradução . . Disponível em: https://doi.org/10.1002/dta.1743. Acesso em: 05 dez. 2025.

    • APA

      Barth, T., Habenschus, M. D., Moreira, F. L., Ferreira, L. D. S., Lopes, N. P., & Oliveira, A. R. M. de. (2015). In vitro metabolism of the lignan (-)-grandisin, an anticancer drug candidate, by human liver microsomes. Drug Testing and Analysis, 7( 9), 780-786. doi:10.1002/dta.1743

    • NLM

      Barth T, Habenschus MD, Moreira FL, Ferreira LDS, Lopes NP, Oliveira ARM de. In vitro metabolism of the lignan (-)-grandisin, an anticancer drug candidate, by human liver microsomes [Internet]. Drug Testing and Analysis. 2015 ; 7( 9): 780-786.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1002/dta.1743

    • Vancouver

      Barth T, Habenschus MD, Moreira FL, Ferreira LDS, Lopes NP, Oliveira ARM de. In vitro metabolism of the lignan (-)-grandisin, an anticancer drug candidate, by human liver microsomes [Internet]. Drug Testing and Analysis. 2015 ; 7( 9): 780-786.[citado 2025 dez. 05 ] Available from: https://doi.org/10.1002/dta.1743
  • 1

1 - 3 (3 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2025